Private Equity Firm GTCR announced that it had sold its portfolio company Actient Holdings to Auxilium Pharmaceuticals Inc.

GTCR was established in 1980, as a private equity firm that’s main focus is on investing in growth firms in the Financial Services & Technology, Healthcare and Information Services & Technology markets. The firm, which is based in Chicago, pioneered The Leaders Strategy (TM) – seeking and teaming up with management leaders in core domains to know, buy and build market-leading firms through transformational acquisitions and organic growth. Since it was incepted, GTCR has invested more than 10 billion US Dollars in more than 200 firms. The company has a very impressive and successful track record.
Leading private equity firm, GTCR, has recently announced that it had sold its portfolio company, Actient Holdings, to Auxilium Pharmaceuticals Inc. This firm is a specialty biopharmaceutical company. Actient Holdings is based in Lake Forest, Illinois, and is a specialty pharmaceutical firm whose main goal is to focus on creating, buying and marketing products that significantly make patient outcomes better.
Actient Holdings was founded in March of the year 2009, together with GTCR. Through a series of five acquisitions, Actient Holdings built a diversified portfolio of commercial products and pipeline programs to establish a specialty pharmaceutical firm that not yet exists. The company must be entirely focused on the treatment of urological indications.
GTCR Managing Director Dean Mihas ha this to say the their partnership with the Actient Holdings the CEO Ed Fiorentino exemplifies GTCR’s Leaders Strategy (TM). We produced Actient Holdings together with a plan to form an important specialty pharmaceutical business finished the acquisition of the companies and products. Through a series of transactions, Ed and the team have built a growing urology specialty company. This strategic acquisition of the Actient Holdings is the result of this positive partnership as well as GTCR’s healthcare policy.” The Vice President of the GTCR Mr. Ben Daverman added that the Actient Holdings company has been a superb partnership for the GTCR in addition, we are truly grateful of the numerous fine efforts by the Ed and also his management team.”
“I’d like to thank GTCR for their efforts in helping Actient Holdings become a significant specialty company. We have had a great partnership with GTCR and we look forward to working with Auxilium to continue Actient Holding’s efforts to develop products that significantly improve patient outcomes.” said Mr. Fiorentino.
Actient Holdings is a specialty products firm whose main focus is on therapeutics to improve patient outcomes. The firm was originally established to buyout firms and products with a focus on select physician specialties